The lentiviral vectors market involves the production and application of genetically engineered lentiviruses, especially HIV-1, as gene delivery vehicles. Lentiviral vectors have become the preferred tools for integrating therapeutic or reporter genes into the genome of non-dividing cells like neurons. They can deliver transgenes into the nucleus and integrate them into the chromosomes of infected cells. The strong transcription ability of lentiviral long terminal repeats allows long-term expression of the delivered genes. Lentiviral vectors hold potential in treating monogenic diseases, cancer, and neurological disorders.

The Global lentiviral vectors market is estimated to be valued at US$ 336.39 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period from 2024 to 2031.

Key Takeaways
Key players operating in the lentiviral vectors market are Tata Communications Ltd., Amazon CloudFront ― Inc., Cachefly, CDNetworks Co., Ltd., CDNify Ltd., CDNsun, CDNvideo, CloudFlare, Inc., EdgeCast Networks, Fastly, Proinity LLC, Limelight Networks Inc., Skypark CDN, and Level 3 Communication Inc.

The growing demand for lentiviral vectors in cell and gene therapy research and development is a major factor driving market growth. Various clinical trials evaluating lentiviral vectors for cancer immunotherapy and hemophilia treatment are currently underway.

The Lentiviral Vectors Market Demand  is also witnessing increased global expansion as companies expand their production facilities outside the U.S. and Europe to address unmet needs in Asia and other emerging markets.

Market Drivers
Increasing research investments into fields like regenerative medicine, vaccine development and cancer immunotherapy are fueling the demand for lentiviral vectors. Government support for cell and gene therapy research in major markets like the U.S. and China is also boosting the lentiviral vectors market. Lentiviral vectors offer advantages over other viral vectors in terms of carrying larger transgene payloads and stable integration of therapeutic genes. This is propelling their increasing adoption in clinical research and development.

Get more insights on This Topic- Lentiviral Vectors Market

Leave a Reply

Your email address will not be published. Required fields are marked *